These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of cGAS-STING signalling in liver diseases. Chen R; Du J; Zhu H; Ling Q JHEP Rep; 2021 Oct; 3(5):100324. PubMed ID: 34381984 [TBL] [Abstract][Full Text] [Related]
3. Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease. Qiao JT; Cui C; Qing L; Wang LS; He TY; Yan F; Liu FQ; Shen YH; Hou XG; Chen L Metabolism; 2018 Apr; 81():13-24. PubMed ID: 29106945 [TBL] [Abstract][Full Text] [Related]
4. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice. Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555 [TBL] [Abstract][Full Text] [Related]
5. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372 [TBL] [Abstract][Full Text] [Related]
6. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. Cerboni S; Jeremiah N; Gentili M; Gehrmann U; Conrad C; Stolzenberg MC; Picard C; Neven B; Fischer A; Amigorena S; Rieux-Laucat F; Manel N J Exp Med; 2017 Jun; 214(6):1769-1785. PubMed ID: 28484079 [TBL] [Abstract][Full Text] [Related]
7. The STING in Non-Alcoholic Fatty Liver Diseases: Potential Therapeutic Targets in Inflammation-Carcinogenesis Pathway. Lv J; Xing C; Chen Y; Bian H; Lv N; Wang Z; Liu M; Su L Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297353 [TBL] [Abstract][Full Text] [Related]
8. STING, a promising target for small molecular immune modulator: A review. Liu Y; Lu X; Qin N; Qiao Y; Xing S; Liu W; Feng F; Liu Z; Sun H Eur J Med Chem; 2021 Feb; 211():113113. PubMed ID: 33360799 [TBL] [Abstract][Full Text] [Related]
9. Potential Therapeutic Value of the STING Inhibitors. Zhang S; Zheng R; Pan Y; Sun H Molecules; 2023 Mar; 28(7):. PubMed ID: 37049889 [TBL] [Abstract][Full Text] [Related]
11. Activation of Stimulator of Interferon Genes in Hepatocytes Suppresses the Replication of Hepatitis B Virus. Guo F; Tang L; Shu S; Sehgal M; Sheraz M; Liu B; Zhao Q; Cheng J; Zhao X; Zhou T; Chang J; Guo JT Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717041 [TBL] [Abstract][Full Text] [Related]
12. Cooperation of liver cells in health and disease. Kmieć Z Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749 [TBL] [Abstract][Full Text] [Related]
15. Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D. Motani K; Kosako H J Biol Chem; 2018 May; 293(20):7717-7726. PubMed ID: 29618514 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways. Liu Y; Li J; Chen J; Li Y; Wang W; Du X; Song W; Zhang W; Lin L; Yuan Z J Virol; 2015 Feb; 89(4):2287-300. PubMed ID: 25505063 [TBL] [Abstract][Full Text] [Related]